Apart from its role in impeding cancer cell growth and inducing apoptosis, Galectin-9 is well-known for its immune-suppressive properties, fostering immune-suppressive tumor microenvironments by binding to checkpoint receptors such as PD-1 and Tim-3 (26). The gene discussed is HAVCR2; the disease is cancer.